Connect with us at Gene Therapy Development 2024
Leverage our 50 years of experience and integrated CDMO solutions for your advanced therapy programs
At Rentschler Biopharma, reliability you can trust is more than a promise—it's our commitment. As a global leader in CDMO services for biopharmaceuticals, including advanced therapies, we take pride in our contributions to nearly 25% of FDA-approved biopharmaceuticals in 2023.
We are looking forward to seeing you at this year's Gene Therapy Development Conference
Stand: 1
Date: June 13-14, 2024
Location: ILEC Conference Center, London, UK
Event Website: link
Discover our Service Portfolio
We offer integrated CDMO solutions for viral vector process and analytical development, cGMP manufacturing and QC, complemented by our client program management and regulatory affairs services.
Process Development
Expert Regulatory Consultation
Client Program Management
Get in Touch with our Business Development Team
Are you interested in learning more? We look forward to hearing from you!
Robert Panting
General Manager, ATMP